期刊文献+

肝纤维化中细胞因子的作用 被引量:1

The effect of some cytoldnes in liver fibrosis
原文传递
导出
摘要 肝纤维化是继发于各种形式慢性肝损伤之后的组织修复过程中的代偿反应,它也是慢性肝病发展为肝硬化的必经病理过程。各种病因所引起的慢性肝病绝大多数都有肝纤维化,其中25%~40%最终发展为肝硬化乃至肝癌。因此,肝纤维化的发生机制成为目前慢性肝病的研究热点之一。肝纤维化的形成是一个多因素、多细胞参与的复杂过程。涉及多种细胞因子和蛋白成分表达的改变,细胞因子在肝星形细胞的活化、表型改变中扮演重要角色。此文对部分细胞因子在肝纤维化中的作用作一简要综述。 Liver fibrosis is induced by the compensatory react of hepatic tissue renovation after all kinds of chronic hepatic injuries, and is also an essential phase of liver cirrhosis. Many chronic hepalie injuries develop into liver fibrosis, cirrhosis, even hepatocellular carcinoma. Aeeordingly, the mechanism of liver fibrosis has become an investigative hot spot of chronic liver disease. Liver fibrosis formation is a complex process with multiple factors and many cells, which includes the changes of many eytokines and express of protein component. Cytokines play a eonsiderable role in hepatic stellate cells aetiveation and shape alteration. The research gives a simple summary about the effect of some cytokines in liver fibrosis.
出处 《国际流行病学传染病学杂志》 CAS 2008年第4期285-287,共3页 International Journal of Epidemiology and Infectious Disease
关键词 肝硬化 细胞因子 结缔组织 肝星形细胞 Liver cirrhosis Cytokines Connective tissues Hepatic satellate cells
  • 相关文献

参考文献15

  • 1Shek FW, Benyon RC. How can transforming growth factor beta be targeted usefully to combat liver fibrosis? Eur J Gastroenterol Hepatol, 2004, 16(2): 123-126.
  • 2Yu C, Wang F, Jin C, el al. Role of fibroblasl growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. Am J Pathol, 2003, 163(4) : 1653-1662.
  • 3Campbell JS, Hughes SD, Gilbertson DG, et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA, 2005, 102(9): 3389-3394.
  • 4Anania FA. Leptin, liver, and obese mice-fibrosis in the fat lane. Hepatology, 2002, 36( 1 ) : 246-248.
  • 5Lang T, Ikejima K, Yoshikawa M, et al. Leptin facilitates proliferation of hepatic stellate cells through up-regulation of platelet-derived growth factor receptor. Biochem Biophys Res Commun, 2004, 323 (3): 1091-1095.
  • 6Oben JA, Roskams T, Yang s, et al. Norepinephrine induces hepatic fibrogenesis in leptin deficient ob/ob mice. Biochem Biophys Res Commun, 2003, 308(2): 284-292.
  • 7Ikejima K, Honda H, Yoshikawa M, et al. Leptin augments inflammatory and profibrogenic responses in the mufine liver induced by hepatotoxic chemicals. Hepatology, 2001, 34(2): 288-297.
  • 8Potter JJ, Mezey E. Leptin deficiency reduces but does not eliminate the development of hepatic fibrosis in mice infected with Schistosoma mansoni. Liver, 2002, 22(2): 173-177.
  • 9Honda H, Ikejima K, Hirose M, et al. Leptin is required for fibregenic responses induced by thioacetamide in the murine liver. Hepatology, 2002, 36(1) : 12-21.
  • 10Poter JJ, Rennie-Tankesley L, Mezey E. Influence of leptin in the development of hepatic fibrosis produced in mice by Schistosoma mansoni infection and by chronic carbon tetrachloride administration. J Hepatol, 2003, 38(3):281-288.

二级参考文献15

  • 1病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 2Pasquetto V, Wieland SF, Upfichard SL, et al. Cytokine- sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J Viral,2002, 76(11):5645.
  • 3Robek MD, Wieland SF, Chisari FV. Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J Virol, 2002, 76(7):3570.
  • 4Tapon N, Hall A. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol, 1997,9:86-92.
  • 5Kjoller L,Hall A. Signaling to Rho GTPases. Exp Cei Res, 1999,253: 167-179.
  • 6Yee HF Jr. Rho directs activation-associated changes in rat hepatic stellate cell morphology via regulation of the actin cytoskeleton.Hepatology, 1998,28:843-850.
  • 7Amano M, Chihara K, Kimura K, et al. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science, 1997,275 : 1308-1311.
  • 8Sakata R, Ueno T, Nakamura T, et al. Mechanical stretch induces TGF-beta synthesis in hepatic stellate cells. Eur J Clin Invest,2004,34:129-136.
  • 9Murata T, Arii S, Mori A, et al. Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis. J Surg Res, 2003,114:64-71.
  • 10李漫松,刘新民,迟宝荣,吴扬,刘阳.血清Ⅳ型胶原、透明质酸及板层素对肝纤维化的诊断价值[J].临床肝胆病杂志,1998,14(3):171-173. 被引量:52

共引文献13

同被引文献9

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部